Malnutrition Diagnosis and Management

Introduction to Malnutrition Diagnoses

The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines explicitly state that their terminology aims to support future updates of the ICD system, acknowledging that current ICD classifications may not align with modern clinical nutrition understanding 1, 2, 3

Clinical Nutrition Diagnostic Framework

The Global Leadership Initiative on Malnutrition (GLIM) criteria represent the international consensus for diagnosing malnutrition in clinical settings, using a two-step approach 4
The GLIM criteria include phenotypic criteria such as non-volitional weight loss, low BMI, and reduced muscle mass, as well as etiologic criteria such as reduced food intake or assimilation and disease burden/inflammation 4
The European Society for Clinical Nutrition and Metabolism has established standardized terminology that includes primary malnutrition categories such as disease-related malnutrition with inflammation, disease-related malnutrition without inflammation, and malnutrition without disease 2, 3
Associated conditions include over-nutrition, sarcopenia, and frailty, which are often associated with malnutrition 2, 3

Nutrition Care Process

The Academy of Nutrition and Dietetics developed the Nutrition Care Process (NCP) which includes a standardized four-step model: assessment, nutrition diagnosis, intervention, and monitoring and evaluation 1, 5, 6
The NCP is supported by the European Federation of the Associations of Dietitians (EFAD) and has been implemented in several countries worldwide 1, 5

Screening and Monitoring

All patients in contact with health or elderly care should undergo nutritional risk screening as the first mandatory step in any diagnostic process 1, 5
Validated screening tools include NRS-2002 for surgical and critically ill patients, Subjective Global Assessment (SGA) for geriatric patients, and Mini Nutritional Assessment Short-Form (MNA-SF) for polymorbid patients including those with cognitive dysfunction 4
In nutritionally at-risk patients, food intake equal to or less than 50% of energy requirements over 3 days during hospital stay should trigger nutritional intervention 6

Critical Clinical Implications

Proper documentation of malnutrition diagnoses using ICD coding can significantly affect hospital reimbursements, with studies showing increased payments when malnutrition is appropriately identified and coded
The American Society for Parenteral and Enteral Nutrition recommends that malnutrition be diagnosed and treated promptly to improve patient outcomes 6
The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends that nutritional screening be performed in all patients at risk of malnutrition, and that malnutrition be treated with a personalized nutrition plan 2, 3

Malnutrition Diagnosis and Management

Diagnostic Criteria

The Global Leadership Initiative on Malnutrition (GLIM) criteria require a mandatory two-step approach for diagnosing malnutrition in adults, involving screening with validated tools and diagnostic assessment using at least one phenotypic criterion AND one etiologic criterion 7, 8
For hospitalized patients, the NRS-2002 is recommended as the primary screening tool 7, 8
For geriatric patients, the MNA-SF has high validity and reliability 9
The GLIM criteria include phenotypic criteria such as non-volitional weight loss, low BMI, and reduced muscle mass, and etiologic criteria such as reduced food intake or assimilation and disease burden/inflammation 10, 11, 12, 13

Nutritional Interventions

For non-critically ill hospitalized patients at nutritional risk, oral nutritional supplements (ONS) should be offered immediately, providing 10-12 kcal/kg and 0.3-0.5 g protein/kg daily 10, 11
ONS should be combined with dietary counseling from registered dietitians or clinical nutritionists 7
A detailed treatment plan should be developed to address specific etiologic factors, including reduced intake, inflammation/disease burden, and assimilation problems 9, 14

Monitoring and Reassessment

Nutritional status should be reassessed regularly during hospitalization and at discharge 14
Weight, intake, and functional status should be monitored throughout the hospital stay 14, 10
Muscle mass should be reassessed using available methods 14

Special Considerations

In patients with kidney disease, GLIM criteria have not been validated, and BMI may underestimate malnutrition due to fluid overload 10, 11, 12, 13
In patients with obesity, malnutrition should not be assumed absent, and the same GLIM criteria should be used for screening and assessment 7, 8
In ICU patients with generalized edema, physical examination for muscle and fat loss may be challenging, and imaging modalities may be considered 15

Malnutrition Indicators in Clinical Scenarios

Diagnostic Markers

Low urea levels specifically reflect protein-energy malnutrition, as seen in prolonged starvation states, making it a useful marker for the degree of nutritional compromise, according to Clinical Nutrition guidelines 16
Urea decreases with reduced protein intake and muscle catabolism, directly reflecting inadequate protein intake and the body's adaptive response to preserve nitrogen, as stated by Clinical Nutrition 16
A patient's presentation, including self-starvation, low BMI, amenorrhea, lanugo, and episodes of vomiting, points to significant protein-energy depletion, as indicated by Gastroenterology guidelines 17
The European Society for Clinical Nutrition and Metabolism (ESPEN) diagnostic criteria for malnutrition include a BMI of 18.5, which is met by this patient, indicating severe malnutrition 17

Limitations of Other Markers

Hypokalaemia is not specific to malnutrition and can be influenced by vomiting episodes, refeeding syndrome risk, and acid-base disturbances, as noted by Clinical Nutrition 18, 19
Liver enzymes, such as ALT, are not reliable indicators of malnutrition and can be affected by numerous non-nutritional factors, according to Clinical Nutrition 16
Creatinine reflects muscle mass and kidney function but may be low due to reduced muscle mass in malnutrition, making it less specific, as stated by Clinical Nutrition 16, 20
Haemoglobin is not a specific marker of overall protein-energy malnutrition and can be influenced by multiple factors, including micronutrient deficiencies, chronic disease, and inflammation, as indicated by Gastroenterology and Clinical Nutrition guidelines 17, 20

Clinical Guidelines

The Gastroenterology society explicitly states that serum proteins like albumin should not be used to diagnose malnutrition because they lack specificity for nutritional status and are highly sensitive to inflammation, as noted by Gastroenterology guidelines 17, 21

Malnutrition Screening and Assessment in Hospitalized Patients

First-Line Screening Tools

The European Society for Clinical Nutrition and Metabolism recommends using the NRS-2002 (Nutritional Risk Screening 2002) as the primary screening tool for hospitalized patients, including surgical and critically ill patients 22
The Society of Critical Care Medicine suggests using the Malnutrition Screening Tool (MST) for initial screening, which has high interrater reliability (93-97%) and validated sensitivity/specificity, and is useful across different body compositions 23
The International Association of Gerontology and Geriatrics recommends using the Mini Nutritional Assessment Short-Form (MNA-SF) for geriatric patients and polymorbid patients, including those with cognitive dysfunction 22
The Society of Critical Care Medicine recommends using the Modified NUTrition Risk in the Critically ill (mNUTRIC) score for ICU patients, which incorporates age, comorbidities, APACHE II score, SOFA score, and days in hospital before ICU admission, and has demonstrated good predictive validity for ICU-related complications and 28-day mortality 24, 23

Comprehensive Assessment Tools

The American Society for Parenteral and Enteral Nutrition suggests using the Subjective Global Assessment (SGA) for detailed assessment, which is a validated tool based on medical history and physical examination that focuses on weight change, dietary intake, GI symptoms, functional capacity, and physical findings 23, 25
The Academy of Nutrition and Dietetics recommends using the Nutrition-Focused Physical Exam (NFPE) for hands-on assessment of subcutaneous fat mass, muscle mass, edema, and evaluation of skin, hair, nails, and oral cavity for micronutrient deficiencies 23, 26

Critical Implementation Points

The European Society for Clinical Nutrition and Metabolism recommends that all patients in contact with health or elderly care should undergo nutritional risk screening as the first mandatory step, and re-screening should occur every 7-10 days during hospitalization 22

Special Population Considerations

The National Kidney Foundation suggests using the SGA 7-point scale or Renal Nutritional Screening Tool (R-NST) for kidney disease patients, which showed 97.3% sensitivity and 74.4% specificity in peritoneal dialysis patients 25
The Society of Critical Care Medicine recommends considering imaging modalities for ICU patients with edema, as physical examination for muscle and fat loss may be challenging 23, 26
The International Association of Gerontology and Geriatrics reports that multiple tools have been validated for older adults with COVID-19, including NRS-2002, MNA, MNA-SF, MUST, NRI, GNRI, and mNUTRIC, with nutritional risk prevalence ranging from 27.5% to 100% depending on the tool used 24

NRS‑2002 Is the Preferred Malnutrition Screening Tool for Hospitalized Cancer Patients

Guideline Recommendations

ESPEN recommends the NRS‑2002 as the validated screening tool for hospitalized cancer patients, citing its independent association with postoperative complications and overall survival 27, 28, 29.
The 2025 Advances in Nutrition guideline panel states that NRS‑2002 is more specific (while the SGA is more sensitive) for cancer patients, making these tools the appropriate first‑line options rather than inflammatory markers 27, 30, 31.
NRS‑2002 can be performed without any laboratory tests, requiring only body‑mass index, weight‑history, food‑intake assessment, and disease‑severity information 28, 29.
Validating NRS‑2002 in a specific patient population and linking it to outcomes such as postoperative complications, mortality, and length of stay demonstrates local relevance 32, 31.

Limitations of NLR as a Nutritional Marker

Neutrophil‑to‑lymphocyte ratio (NLR) measures systemic inflammation, not malnutrition; inflammation and malnutrition are distinct pathophysiological processes in cancer patients 27, 30, 31.
Because NRS‑2002 already incorporates disease severity (which reflects inflammation), comparing NLR to NRS‑2002 creates a circular validation where an inflammation marker is tested against a tool that already accounts for inflammatory disease burden 28, 29, 32.
Albumin, pre‑albumin, and total lymphocyte count are negative acute‑phase reactants that decline during inflammation regardless of nutritional status, limiting their utility as isolated nutritional markers 30.

Methodological Considerations for Research

Cross‑sectional designs capture only a single time point and miss the dynamic changes in both inflammation and nutritional status that occur during active cancer treatment 33.
Prospective cohort studies with standardized NRS‑2002 assessment at admission, concurrent NLR measurement, and follow‑up for clinical outcomes (complications, length of stay, mortality) are recommended to evaluate any incremental prognostic value of NLR 32.
Outcome measures beyond NRS‑2002—such as postoperative complications, 30‑day mortality, length of stay, and readmission rates—should be incorporated to assess clinical relevance 27, 32, 31.
In typical hospitalized cancer cohorts, malnutrition prevalence ranges from 40 % to 50 %; even modest specificity of a screening test can generate a substantial number of false‑positive results 32, 33.

Clinical Implementation Advice

Current guidelines and high‑quality evidence do not support using NLR as a standalone malnutrition screening tool; the focus should remain on implementing and validating NRS‑2002, with inflammatory markers (e.g., NLR, CRP) considered only as adjuncts for prognostic stratification 27, 28, 29, 32.